Authorities in Rajasthan have banned a substandard oxytocin injection batch linked to a maternal deaths probe in Kota and launched action against the supplier company. Experts said the drug lacked the active ingredient but was unlikely to directly cause deaths, kidney failure or other fatal complications in affected women.